i-Tracker Vedolizumab
Product Description
i-Tracker Vedolizumab is an automated assay intended for the quantitative measurement of Vedolizumab (anti-α4β7 integrin) in human serum or plasma samples.
- Innovative CLIA technology
- Quantitative measurement of drug and anti-drug antibodies
- First results in less than 35 minutes; 60 results/hour
- Validated on princeps and biosimilars
- Controls and calibrators included
-
- Cherry LN & al., Vedolizumab: an α4β7 integrin antagonist for ulcerative colitis and Crohn’s disease, Therapeutic Avdances in Chronic Disease, Vol.6(5), 224-233, 2015.
- Feagan BG & al., Induction and Maintenance Therapy with Vedolizumab, a novel biologic therapy for ulcerative colitis, Gastroenterology & Hepatology, 10, Issue 1, 2014.
- Feagan BG & al., Vedolizumab as induction and maintenance therapy for ulcerative colitis, The new England journal of medicine, 369, 699-710, 2013.
- Sandborn WJ. & al., Vedolizumab as induction and maintenance therapy for crohn’s disease, The new England journal of medicine, 369, 711-721, 2013.
- Rosario M. & al., Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn’s disease, Alimentary Pharmacology and Therapeutics, 2015.
- Aardoom MA & al., Vedolizumab trough levels in childrens with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2020 Oct;71(4):501-507
- Guidi L & al., Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease. United European Gastroenterol J. 2019 Nov;7(9):1189-1197.
- Vaughn BP. & al. Vedolizumab Serum Trough Concentrations and Response to Dose Escalation in Inflammatory Bowel Disease. J Clin Med. 2020 Sep 28;9(10):E3142.
- Product Code: CTV 002-50
- Number of Tests: 50
- Sample Type: Serum or plasma
- Sample Volume: 5 µL
- Assay Range: 1 - 60 µg/mL
- Add to Enquiry Basket
Interested? Enquire now.
Add to Enquiry Basket
Related Products
| Assays | Certification | Platform | Clinical Area | Portfolio | RUO/IVD |
|---|---|---|---|---|---|
| i-Tracker anti-Vedolizumab | CE Marked | i10iSYS | Therapeutic Drug Monitoring | TDM | IVD |
| i-Tracker Infliximab | CE Marked | i10iSYS | Therapeutic Drug Monitoring | TDM | IVD |
| i-Tracker Adalimumab | CE Marked | i10iSYS | Therapeutic Drug Monitoring | TDM | IVD |
| i-Tracker Golimumab | CE Marked | i10iSYS | Therapeutic Drug Monitoring | TDM | IVD |
| i-Tracker Ustekinumab | CE Marked | i10iSYS | Therapeutic Drug Monitoring | TDM | IVD |